Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo.

Hudacek, Andrew W; Al-Saleem, Fetweh H; Willet, Mallory; Eisemann, Travis; Mattis, Jeffrey A; Simpson, Lance L; Schnell, Matthias J

Hudacek, Andrew W; Al-Saleem, Fetweh H; Willet, Mallory; Eisemann, Travis; Mattis, Jeffrey A; Simpson, Lance L; Schnell, Matthias J.

Afiliação

Hudacek AW; Molecular Targeting Technologies, Inc. , West Chester, Pennsylvania, USA ; Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University , Philadelphia, Pennsylvania, USA.
Al-Saleem FH; Inventox, Inc., Lankenau Institute for Medical Research , Wynnewood, Pennsylvania, USA.
Willet M; Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University , Philadelphia, Pennsylvania, USA.
Eisemann T; Department of Biochemistry, Sidney Kimmel Medical College, Thomas Jefferson University , Philadelphia, Pennsylvania, USA.
Mattis JA; Molecular Targeting Technologies, Inc. , West Chester, Pennsylvania, USA.
Simpson LL; Inventox, Inc., Lankenau Institute for Medical Research , Wynnewood, Pennsylvania, USA.
Schnell MJ; Department of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University , Philadelphia, Pennsylvania, USA ; Department of Biochemistry, Sidney Kimmel Medical College, Thomas Jefferson University , Philadelphia, Pennsylvania, USA ; Jefferson Vaccine Center, Thomas Jeffer

Mol Ther Methods Clin Dev ; 1: 14046, 2014.

Article em En | MEDLINE | ID: mdl-26015984

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Mol Ther Methods Clin Dev Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google